On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site

Scholarly Works

• Zhou, L.; Lu, Y.; Liu, W.; Wang, S.; Wang, L.; Zheng, P.; Zi, G.; Liu, H.; Liu, W.; Wei, S. Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice. Experimental hematology & oncology 2024, 13, 26. doi:10.1186/s40164-024-00493-8
• Zhang, J.; Hu, F.; Aras, O.; Chai, Y.; An, F. Small Molecule-Drug Conjugates: Opportunities for the Development of Targeted Anticancer Drugs. ChemMedChem 2024, e202300720. doi:10.1002/cmdc.202300720
• Budka, J.; Debowski, D.; Mai, S.; Narajczyk, M.; Hac, S.; Rolka, K.; Vrettos, E. I.; Tzakos, A. G.; Inkielewicz-Stepniak, I. Design, Synthesis, and Antitumor Evaluation of an Opioid Growth Factor Bioconjugate Targeting Pancreatic Ductal Adenocarcinoma. Pharmaceutics 2024, 16, 283. doi:10.3390/pharmaceutics16020283
• Guo, X.-Y.; Yi, L.; Yang, J.; An, H.-W.; Yang, Z.-X.; Wang, H. Self-assembly of peptide nanomaterials at biointerfaces: molecular design and biomedical applications. Chemical communications (Cambridge, England) 2024, 60, 2009–2021. doi:10.1039/d3cc05811e
• Wang, Y.; Zhang, L.; Liu, C.; Luo, Y.; Chen, D. Peptide-Mediated Nanocarriers for Targeted Drug Delivery: Developments and Strategies. Pharmaceutics 2024, 16, 240. doi:10.3390/pharmaceutics16020240
• Mező, G.; Gomena, J.; Ranđelović, I.; Dókus, E. L.; Kiss, K.; Pethő, L.; Schuster, S.; Vári, B.; Vári-Mező, D.; Lajkó, E.; Polgár, L.; Kőhidai, L.; Tóvári, J.; Szabó, I. Oxime-Linked Peptide-Daunomycin Conjugates as Good Tools for Selection of Suitable Homing Devices in Targeted Tumor Therapy: An Overview. International journal of molecular sciences 2024, 25, 1864. doi:10.3390/ijms25031864
• Rizvi, S. F. A.; Zhang, L.; Zhang, H.; Fang, Q. Peptide-Drug Conjugates: Design, Chemistry, and Drug Delivery System as a Novel Cancer Theranostic. ACS pharmacology & translational science 2024, 7, 309–334. doi:10.1021/acsptsci.3c00269
• Zeng, W.; Xue, J.; Geng, H.; Liu, X.; Yang, J.; Shen, W.; Yuan, Y.; Qiang, Y.; Zhu, Q. Research progress on chemical modifications of tyrosine residues in peptides and proteins. Biotechnology and bioengineering 2023, 121, 799–822. doi:10.1002/bit.28622
• Ahmed, Y. W.; Tsai, H.-C.; Wu, T.-Y.; Darge, H. F.; Chen, Y.-S. Role of thermal and reactive oxygen species-responsive synthetic hydrogels in localized cancer treatment (bibliometric analysis and review). Materials Advances 2023, 4, 6118–6151. doi:10.1039/d3ma00341h
• Sviben, I.; Glavaš, M.; Erben, A.; Bachelart, T.; Pavlović Saftić, D.; Piantanida, I.; Basarić, N. Dipeptides Containing Pyrene and Modified Photochemically Reactive Tyrosine: Noncovalent and Covalent Binding to Polynucleotides. Molecules (Basel, Switzerland) 2023, 28, 7533. doi:10.3390/molecules28227533
• Koutsopetras, I.; Mishra, A. K.; Benazza, R.; Hernandez-Alba, O.; Cianférani, S.; Chaubet, G.; Nicolai, S.; Waser, J. Cysteine-Cysteine Cross-Conjugation of both Peptides and Proteins with a Bifunctional Hypervalent Iodine-Electrophilic Reagent. Chemistry (Weinheim an der Bergstrasse, Germany) 2023, 29, e202302689. doi:10.1002/chem.202302689
• Biniari, G.; Markatos, C.; Nteli, A.; Tzoupis, H.; Simal, C.; Vlamis-Gardikas, A.; Karageorgos, V.; Pirmettis, I.; Petrou, P.; Venihaki, M.; Liapakis, G.; Tselios, T. Rational Design, Synthesis and Binding Affinity Studies of Anthraquinone Derivatives Conjugated to Gonadotropin-Releasing Hormone (GnRH) Analogues towards Selective Immunosuppression of Hormone-Dependent Cancer. International journal of molecular sciences 2023, 24, 15232. doi:10.3390/ijms242015232
• Jalil, A. T.; Abdulhadi, M. A.; Al-Ameer, L. R.; Taher, W. M.; Abdulameer, S. J.; Abosaooda, M.; Fadhil, A. A. Peptide-Based Therapeutics in Cancer Therapy. Molecular biotechnology 2023. doi:10.1007/s12033-023-00873-1
• Xu, J.; Song, M.; Fang, Z.; Zheng, L.; Wang, J.; Liu, K. A chemoimmunotherapy-based strategy to enhance tumor therapy by cross-linking a novel size-variable nanocluster via a bifunctional peptide. Materials & Design 2023, 233, 112232. doi:10.1016/j.matdes.2023.112232
• Ma, H.; Pan, Z.; Lai, B.; Zan, C.; Liu, H. Recent Research Advances in Nano-Based Drug Delivery Systems for Local Anesthetics. Drug design, development and therapy 2023, 17, 2639–2655. doi:10.2147/dddt.s417051
• Tan, X.; Le, M.; Wang, H.; Huo, B.; Yu, T.; Huang, P.; Luan, T.; Wen, S. Design and synthesis of peptide-drug conjugates to double target EGFR. Phytochemistry Letters 2023, 56, 30–37. doi:10.1016/j.phytol.2023.06.003
• Ogundipe, O. D.; Olajubutu, O.; Adesina, S. K. Targeted drug conjugate systems for ovarian cancer chemotherapy. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023, 165, 115151. doi:10.1016/j.biopha.2023.115151
• Davis, R. A.; Ganguly, T.; Harris, R.; Hausner, S. H.; Kovacs, L.; Sutcliffe, J. L. Synthesis and Evaluation of a Monomethyl Auristatin E─Integrin αvβ6 Binding Peptide-Drug Conjugate for Tumor Targeted Drug Delivery. Journal of medicinal chemistry 2023, 66, 9842–9852. doi:10.1021/acs.jmedchem.3c00631
• Ziaei, E.; Paiva, I. M. d.; Yao, S.-J.; Sarrami, N.; Mehinrad, P.; Lai, J.; Lavasanifar, A.; Kaur, K. Peptide-Drug Conjugate Targeting Keratin 1 Inhibits Triple-Negative Breast Cancer in Mice. Molecular pharmaceutics 2023, 20, 3570–3577. doi:10.1021/acs.molpharmaceut.3c00189
• Puc Encalada, I.; Carrillo Cocom, L. M.; Quintal Bojórquez, N. d. C.; Segura Campos, M. R. Bibliometric Analysis of the Role of Bioactive Peptides in Cancer Therapy. International Journal of Peptide Research and Therapeutics 2023, 29. doi:10.1007/s10989-023-10538-x

Explore citations to this article at